Glazer Capital LLC’s Pandion Therapeutics Inc. Common Stock PAND Stock Holding History

Glazer Capital LLC’s Portfolio PAND Stock Details PAND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,000	Closed	-$60K	–	1092
2021 Q1	$60K	Buy	+1,000	New	+$36.2K	﹤0.01%	722

Glazer Capital LLC's PAND Position: Q2 2021 in Review

Glazer Capital LLC sold out of Pandion Therapeutics Inc. Common Stock (PAND) in Q2 2021, closing a stake of 1,000 shares — an estimated $60K sold.

Glazer Capital LLC first reported a position in PAND in Q1 2021 and held it in 1 quarter. The position peaked at $60K in Q1 2021. 0 funds tracked by Wall St. Rank hold PAND as of Q2 2021.

Glazer Capital LLC reported no remaining Pandion Therapeutics Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Glazer Capital LLC sold 1,000 Pandion Therapeutics Inc. Common Stock shares in Q2 2021, an estimated $60K.
Glazer Capital LLC first reported a position in Pandion Therapeutics Inc. Common Stock in Q1 2021 and held it in 1 quarter.
Glazer Capital LLC's Pandion Therapeutics Inc. Common Stock position peaked at $60K in Q1 2021.
0 funds tracked by Wall St. Rank held Pandion Therapeutics Inc. Common Stock as of Q2 2021.

Based on Glazer Capital LLC's 13F filing for Q2 2021, filed 13 Aug 2021.